114
Participants
Start Date
December 31, 2004
Primary Completion Date
August 31, 2008
Study Completion Date
February 28, 2010
Pegylated Interferon/ribavirin
Columbia University Medical Center, New York
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Johns Hopkins University, Baltimore
University of Florida, Gainesville
The Children's Hospital, Denver
Children's Hospital and Regional Medical Center, Seattle
University of California, San Francisco, San Francisco
Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis
Children's Hospital Boston, Boston
Children's Hospital Medical Center, Cincinnati
Roche Pharma AG
INDUSTRY
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH